• Accueil >
  • Publications >
  • Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial

1 avr. 2015The Lancet Oncology

DOI : 10.1016/s1470-2045(15)70070-7

Auteurs

Patricia Pautier, Anne Floquet, Christine Chevreau, Nicolas Penel, Cécile Guillemet, Corinne Delcambre, Didier Cupissol, Frédéric Selle, Nicolas Isambert, Sophie Piperno-Neumann, Antoine Thyss, François Bertucci, Emmanuelle Bompas, Jerôme Alexandre, Olivier Collard, Sandrine Lavau-Denes, Patrick Soulié, Maud Toulmonde, Axel Le Cesne, Benjamin Lacas, Florence Duffaud